Member Info for Wilson63

Results from paper for those with a busy lifestyle

Results the five SARS-CoV-2 single nucleotide polymorphisms (SNPs) were selected for their reportedassociationwith (i) an increase in SARS-CoV-2 transmission and / or (ii) diminished efficacy of monoclonal antibody therapy, convalescent plasma therapy, vaccine derived immunity, or naturally acquired immunity.10The sequences with more than 1% ambiguous bases were removed from the original dataset of 781,815 sequences. The remaining 640,482sequences were investigated usingthe VOC Genie algorithmdescribed in the Figure 1 below:At step (1) 640,482sequenceswere assessed for the presence of the N501Y mutation associated with increased transmission.324,234 sequences contained the SNPwhile 316,248 were wild typeand assessed at step (2)for the E484K and L452Rescape mutations.Surprisingly, 7,979 sequences contained the E484K mutation but did not contain the N501Y nor B.1.1.7identifiers. At step(3), only 2,866 sequences contained the E484K escape mutation while B.1.1.7was detected in over 321k sequences. The L452R SNP was detected in 13 sequences (4)
The panel of five SNP's detected all voc's and mutations of biological significance.

Now that's what you call a trial.

Company tweet with paper included some will have read this but for those that haven't great read one of the authors being jo Martin of Queen Mary fame.

https://twitter.com/NovacytGroup/status/1394209324713627649

Bing007 I wasn't querying what you said fat fingers good start, Amers has the worm turned:)

French ??

Levincoolpal just going out door and without cross ref I THINK it's the 3bn one as I say THINK, happy to be corrected.

Company tweet

https://twitter.com/NovacytGroup/status/1394177926577467393

Had to read that a couple of times love this paragraph

SNPsig® SARS-CoV-2 (E484K) Easy is a research-use-only, streamlined workflow solution for the detection of SARS-CoV-2 variants carrying the E484K escape mutation for use with the Company's q32 rapid-PCR instrument. This assay comes with pre-filled cassettes and includes only one pipetting step to decrease operator complexity and improve cycle times.

Why? For the words "company's q32" beautiful.

Levincoolpal fair post , hope your loss is reversed soon.

Harchris my conscience comment was in regards to ramping the share, now complementing barnetpeter on one board whilst criticising him on another is a bit rich. So if your in until 6.00 ish stop blaming "rampers" for supporting the share.

Harchris funnily enough some of us don't change our stance depending if we are in or out and actually try to promote the company by sharing research that others have found that may be of interest, my conscience is clear, now if your in for the time being let's try and support the share, your a trader good for you but don't be a smart arse towards those of us that are investors. Regards Wilson.

Company tweet

https://twitter.com/NovacytGroup/status/1393942095723966465

Now what would be rampy is if I then said oh wonder what tomorrow will bring but I'm obviously not going to say that.

Oh from r and d rns

Expansion of the PROmate™ PCR portfolio

PROmate™ remains the only direct-to-PCR assay approved by the UK's Technology Validation Group and enables near-to-patient testing with results in under 90 minutes. The current CE-IVD PROmate™ COVID-19 test identifies the SARS-CoV-2 ORF1ab gene. Due to an emerging need in some countries, the Company expects to launch a second CE-IVD PROmate™ COVID-19 test in May 2021 to identify both the SARS-CoV-2 ORF1ab gene and M gene.

Imho Dyor.

Hi fonzey here's their homepage can't find a mention of pcr

https://www.dnafit.com/

Interesting article found by uk2day

http://www.dailynews.lk/2021/05/15/features/249334/race-sequence-genomes-covid-surges

ShaunP I went as a topic wrapper and got rustled on victoria road so no info to share.

Morning soder Tks for your constructive positivity on here good to read.

On the subject of airport testing , I think the same day test will appeal to buisness people having to suddenly book a flight and (madness) the because I can group sounds crazy, I'm wealthy I'm important, look at me
and I'm sure a number of legitimate reasons, imho of course.

Hopeful we are supplying to at least 25% of the fit2fly companies alas opinion is there is not sufficient supply of pcr across the board for this, so I'd presume as much as we can realistically allocate to this area.

What will Monday bring for us.

You would think she'd get struck off

Crazy Gizmo555 improving Tks

https://www.standard.co.uk/news/crime/sohyla-mohamed-pcr-covid-test-fly-doctor-fraud-certificate-b935236.html

B2 very informative thank you.
now I'm off to take this topic wrapper off think I opened the wrong link!!!

Company tweet

https://twitter.com/NovacytGroup/status/1393121417751896064